Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy

2010350 citationsJournal Article

Authors

Massimo Iavarone · Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Giuseppe Cabibbo · University of Palermo

Fabio Piscaglia · Policlinico S.Orsola-Malpighi

Claudio Zavaglia · Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda

Antonio Grieco · Università Cattolica del Sacro Cuore

Erica Villa · University of Modena and Reggio Emilia

Calogero Cammà

Abstract

Overall, safety, effectiveness, and generalizability of sorafenib therapy in HCC was validated in field practice. The effectiveness of half-dosed sorafenib may have implications for tailored therapy.

Topics & Keywords

Hepatocellular Carcinoma Treatment and Prognosis Cancer Mechanisms and Therapy Cholangiocarcinoma and Gallbladder Cancer Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Hepatology

Volume 54, Issue 6, pp. 2055-2063

DOI: 10.1002/hep.24644

Field-Weighted Citation Impact: 8.42